STANDEX INTERNATIONAL CORP/DE/ financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data STANDEX INTERNATIONAL CORP/DE/ files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	755	596	640	605	656	735	741	721	790	892
Cost of revenue	432	370	405	389	415	465	456	439	475	520
Gross profit	216	226	235	215	241	270	285	282	315	372
Research and development								20.5	21.2	24.2
Selling, general and administrative	145	141	150	148	163	170	172	170	193	219
Operating income	56.9	78.1	79.5	60.5	59.2	88.3	171	102	93.5	194
Interest expense	4.04	8.03	10.8	7.48	5.99	5.87	5.41	4.54	23.9	30.7
Other non-operating income	-5.96	-9.75	-12.5	-6.45	-0.47	-1.13	-1.74	-2.07	-0.81	0.07
Pre-tax income	51	68.4	67	54.1	52.7	81.3	164	95.1	68.8	163
Income tax	11.8	38	18.7	13.1	14.2	19.8	24.8	21.5	11.1	34.3
Income from continuing operations	39.1	30.4	48.3	41	38.5	61.5	139	73.6
Net income to minority interests							0	0	1.92	23.9
Net income	46.5	36.6	67.9	20.2	36.5	61.4	139	73.1	55.8	105
EBITDA	74.7	103	109	92.8	92.4	118	200	130	129	232
EPS, basic	3.68	2.88	5.40	1.64	3.00	5.13	11.77	6.22	4.68	8.69
EPS, diluted	3.65	2.86	5.38	1.63	2.97	5.06	11.58	6.14	4.64	8.67
Shares, basic (weighted)	12.7	12.7	12.6	12.3	12.2	12	11.8	11.8	11.9	12
Shares, diluted (weighted)	12.8	12.8	12.6	12.4	12.3	12.1	12	11.9	12	12.1
Dividend per share		0.70	0.78	0.86	0.94	1.02	1.10	1.18	0.94	1.34

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	88.6	110	93.1	119	136	105	196	154	105	179
Receivables	127	120	103	98.2	110	117	123	121	173	173
Inventory	119	104	76.3	85	91.9	105	98.5	87.1	130	129
Other current assets	8.4	10.3	21.8	18.9	23.5	45.2	34.4	22	14.4	26.8
Total current assets	361	384	334	332	374	379	483	430	481	552
Property, plant and equipment	133	137	134	133	133	129	131	135	160	153
Lease right-of-use assets			0	44.8	37.3	39.1	33.3	37.1	48	45.4
Goodwill	243	204	274	271	278	268	265	281	610	582
Intangible assets	103	84.9	119	106	98.9	85.8	75.7	78.7	226	199
Other non-current assets	27.3	29.7	25.1	26.6	30.7	25.9	22.4	25.5	29.6	50.1
Total assets	868	917	922	931	962	934	1,025	1,005	1,567	1,586
Accounts payable	96.5	78.9	54.2	54.9	74.8	74.5	68.6	63.4	88	80.1
Accrued liabilities	58.7	57.7	50.2	59.9	61.7	67.8	62	56.7	63.2	68
Total current liabilities	160	161	142	123	144	151	141	128	167	230
Long-term debt	192	194	198	199	199	175	173	149	553	518
Lease liabilities			0	36.3	29	31.4	25.8	30.7	40.1	35.8
Other non-current liabilities	11.3	26.3	20.4
Total liabilities	459	466	458	469	456	435	417	384	855	830
Total debt	192	194	198	199	199	175	173	149	553	518
Paid-in capital	56.8	61.3	65.5	72.8	80.8	91.2	101	106	136	128
Retained earnings	717	761	818	828	852	901	1,027	1,086	1,127	1,215
Treasury stock	-291	-292	-324	-333	-353	-382	-404	-430	-428	-431
Other comprehensive income	-116	-122	-137	-148	-116	-153	-158	-183	-165	-199
Shareholders' equity	409	451	464	462	506	499	607	622	712	755
Total equity	409	451	464	462	506	499	607	622	712	755
Total liabilities and equity	868	917	922	931	962	934	1,025	1,005	1,567	1,586
Shares outstanding	12.7	12.7	12.3	12.2	12	11.8	11.7	11.8	12	12.1

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	46.5	36.6	67.9	20.2	36.5	61.4	139	73.1	57.7	129
Depreciation and amortization	17.8	25	29.3	32.3	33.2	29.7	28.5	28.1	35.4	38.7
Stock-based compensation	5.02
Deferred income tax	-0.12	7.39	-3.44	-0.1	0.84	-1.97	-7.13	-2.76	-9.67	1.41
Change in receivables	-8.28	-7.35	7.18	2.33	-5.54	-11.6	-9.64	16.2	-13.8	-7.15
Change in inventory	-4.48	-10	7.2	-9.05	-7.72	-18.2	-0.91	17.1	-16.1	-16.3
Change in payables	5.56	-4.87	-2.07	0.17	17.6	6.13	-3.15	-13.9	14	5.97
Cash from operations	63.4	64.9	73.3	47.2	83.6	77.7	90.8	92.7	69.6	89.6
Capital expenditures		-23.6	-32.5	-21.5	-21.8	-23.9	-24.3	-20.3	-28.3	-25.2
Acquisitions	-154	-10.4	-128	-0.62	-27.4	-13	0	-48.8	-479	0
Purchases of investments							-2.7	-2.7
Cash from investing	-179	-32.3	-49.7	-0.62	-39.1	-31	41.6	-61.6	-503	43.1
Debt issued							225	0	792	75
Debt repaid							-226	-25	-389	-110
Share buybacks	-7.81	-2.65	-33.4	-10.4	-21.2	-31.4	-25.5	-31.8	-9.91	-4.4
Dividends paid	-7.85	-8.89	-9.83	-10.6	-11.4	-12.2	-13	-13.9	-15	-16.2
Cash from financing	84.7	-11.9	-38.2	-19	-31.7	-69.4	-40	-69.2	380	-56.6
Exchange rate effect	-2.5	0.29	-1.93
Net change in cash	-33.4	21	-16.5	25.7	17.6	-31.5	90.9	-41.5	-49.7	74.2
Free cash flow		41.4	40.8	25.7	61.8	53.8	66.5	72.4	41.3	64.4
Interest paid	3.26	6.18	9.47	6.32	4.9	4.75	4.23	4.09	21.2	30.7
Income taxes paid	20.4	22.1	24	18.7	17.2	18	26.2	28	27.7	38

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $280.17 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	41.7%	Gross profit / revenue.
Operating margin	21.7%	Operating income / revenue.
EBITDA margin	26.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	18.3%	Pre-tax income / revenue.
Net margin	11.7%	Net income / revenue.
FCF margin	7.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	10.0%	Cash from operations / revenue.
Effective tax rate	21.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	14.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	6.6%	Net income / average total assets.
Return on invested capital (ROIC)	13.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	2.7%	Research and development expense / revenue.
SG&A / revenue	24.6%	Selling, general and administrative expense / revenue.
Capex / revenue	2.8%	Capital expenditures / revenue.
D&A / revenue	4.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	12.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	6.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	18.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	9.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	9.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	106.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	4.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	26.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	80.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	5.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	20.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	87.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-9.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	23.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	86.9%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-9.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	23.9%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	28.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-0.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	1.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	56.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-1.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	0.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	42.6%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	6.8%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	7.3%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	6.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	7.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	8.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	15.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.40x	Current assets / current liabilities.
Quick ratio	1.53x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.78x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.69x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	32.7%	Total debt / total assets.
Liabilities / assets	52.4%	Total liabilities / total assets.
Net debt	$339.2M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.46x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	6.30x	Operating income / interest expense.
Working capital	$322.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	49.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$25.8M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.57x	Revenue / average total assets.
Fixed asset turnover	5.69x	Revenue / average property, plant and equipment.
Inventory turnover	4.01x	Cost of revenue / average inventory.
Days inventory	91 days	365 x average inventory / cost of revenue.
Receivables turnover	5.16x	Revenue / average receivables.
Days sales outstanding	71 days	365 x average receivables / revenue.
Days payables	59 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	103 days	Days inventory + days sales outstanding - days payables.
FCF conversion	61.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	28.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$8.67	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$8.69	Net income per basic share, as reported (split-adjusted).
Revenue per share	$73.87	Revenue / diluted weighted shares.
FCF per share	$5.33	Free cash flow / diluted weighted shares.
Operating cash flow per share	$7.42	Cash from operations / diluted weighted shares.
Book value per share	$62.65	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$2.14	Tangible book value / shares outstanding.
Cash per share	$14.83	(Cash + short-term investments) / shares outstanding.
Dividend per share	$1.34	Dividend declared per common share (paid, when declared is not tagged).
Payout ratio	15.5%	Dividends paid / net income, when net income is positive.
Dividends / FCF	25.1%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	6.8%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$3.40B	Share price x shares outstanding.
Enterprise value	$3.73B	Market cap + total debt - cash - short-term investments.
P/E	32.5x	Market cap / net income. Only when net income is positive.
P/S	3.81x	Market cap / revenue.
P/B	4.50x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	52.8x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	37.9x	Market cap / cash from operations, when positive.
EV/Sales	4.19x	Enterprise value / revenue.
EV/EBIT	19.3x	Enterprise value / operating income, when both are positive.
EV/EBITDA	16.1x	Enterprise value / EBITDA, when both are positive.
EV/FCF	58.0x	Enterprise value / free cash flow, when both are positive.
FCF yield	1.9%	Free cash flow / market cap.
Earnings yield	3.1%	Net income / market cap (the inverse of P/E).
Dividend yield	0.5%	Dividends paid over the period / market cap.
Shareholder yield	0.6%	(Dividends paid + share buybacks) / market cap.

What was STANDEX INTERNATIONAL CORP/DE/'s revenue in fiscal 2026?

STANDEX INTERNATIONAL CORP/DE/ reported revenue of $891.6M for fiscal 2026, 12.8% higher than the year before.

Was STANDEX INTERNATIONAL CORP/DE/ profitable in fiscal 2026?

Yes. Net income was $104.6M, a net margin of 11.7%.

How much free cash flow did STANDEX INTERNATIONAL CORP/DE/ generate in fiscal 2026?

Cash from operations of $89.6M minus capital expenditures of $25.2M left free cash flow of $64.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to STANDEX INTERNATIONAL CORP/DE/